It’s one biotech working to give sight to the blind, and its stock is up more than 30 percent this year. » Subscribe to CNBC: » Watch …
source CNBC
Spark Therapeutics CEO: Giving Sight To The Blind | Mad Money | CNBC
It’s one biotech working to give sight to the blind, and its stock is up more than 30 percent this year. » Subscribe to CNBC: » Watch …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More